<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Galanin receptor pathway" Version="20180814" Email="keshav@yenepoya.edu" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Galanin, a 29-30 amino acid neuropeptide named to be so, as a glycine residue occupies the position at N-terminal and an alanine residue at C-terminal. Galanin is expressed in the central and peripheral nervous systems in mammalian species. The galanin family of peptides includes &#8216;GMAP&#8217; (Gaalanin- Message associated peptide), &#8216;GALP&#8217; (Galanin-like Peptide), and its splice variant &#8216;Alarin&#8217; along with Galanin. There are three known G-protein coupled receptor subtypes of Galanin, namely, GALR1, GALR2, and GALR3. Galaninergic signaling is predominantly inhibitory which mainly involves MAPK, AKT, AC pathways Galanin peptides have a wide range of non-neuronal functions as well as classic neuromodulatory roles, therefore it is recommended to consider as regulatory peptides. Galanin in general is associated with several biological functions such as arousal and sleep regulation, nociception, learning, inflammation, feeding, and neuroendocrine regulation. It is also implicated in diseases like Alzheimer&#8217;s, depression, epilepsy, mood disorders, stress, anxiety, diabetes mellitus, and chronic pain.

The creation of this pathway is described in [https://pubmed.ncbi.nlm.nih.gov/33136286/ Gopalakrishnan et al.]</Comment>
  <BiopaxRef>e66</BiopaxRef>
  <Graphics BoardWidth="6757.848101265824" BoardHeight="2546.2337662337663"/>
  <DataNode TextLabel="KRT19" GraphId="ca5d9" Type="Rna" GroupRef="f2837">
    <Comment>[Pubmed:28196718] have shown that M617 stimulates GALR1 and induces upregulation of KRT19 gene in Male Sprague- Dawley rats.</Comment>
    <BiopaxRef>a25</BiopaxRef>
    <Graphics FillColor="Transparent" FontStyle="Italic" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="SLC2A4" GraphId="be028" Type="Protein" GroupRef="ef24f">
    <Comment>[Pubmed:27127795] have shown that  M617 stimulates GalR1 and induces upregulation of  SLC2A4 in total cell membrane and plasma membrane fractions of Male Wistar Rats adipocytes.</Comment>
    <Comment>[Pubmed:27410235] have shown that M617 stimulates GALR1 and induces upregulation of SLC2A4 in plasma membrane of myocytes in diabetic rats.</Comment>
    <Comment>[Pubmed: 27041232] have shown that M617 stimulates GALR1 and induces upregulation of SLC2A4 in plasma membranes of skeletal muscles in diabetic rats.</Comment>
    <BiopaxRef>df7</BiopaxRef>
    <BiopaxRef>e84</BiopaxRef>
    <BiopaxRef>cb4</BiopaxRef>
    <Graphics ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="CRP" GraphId="ae89f" Type="Protein" GroupRef="ef24f">
    <Comment>[Pubmed:27127795] have shown that  M617 stimulates GalR1 and induces downregulation of plasma CRP in  Male Wistar Rats adipocytes.</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>df7</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="009900"/>
    </DataNode>
  <DataNode TextLabel="FOS" GraphId="aa167" Type="Protein" GroupRef="fdad2">
    <Comment>[Pubmed:19272414]have shown that GAL stimulates GALR1 and induces the activation of FOS in Locus coeruleus of C57BL6/J mice brain.</Comment>
    <Comment>[Pubmed:25405608] have shown that GAL&#160;stimulates GalR1 and &#160;induces the upregulation of FOS in&#160;dorsomedial nucleus of the hypothalamus of&#160;Male Wistar-Han rat.</Comment>
    <BiopaxRef>d71</BiopaxRef>
    <BiopaxRef>a65</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="INS" GraphId="cdda1" Type="Protein" GroupRef="b4a4f">
    <Comment>[Pubmed:27041232] have shown that M617 stimulates GALR1 and induces downregulation of INS in diabetic rats. </Comment>
    <Comment>[Pubmed:27410235] have shown that M617 stimulates GALR1 and induces downregulation of INS in blood of diabetic rats.</Comment>
    <Comment>[Pubmed:25690510] have shown that NAX-5055 stimulates GALR1 and induces downregulation of INS in CF-1 mice.</Comment>
    <Comment> [Pubmed:25449850] have shown that M617 stimulates GALR1 and induces downregulation of INS in cardiac muscle of diabetic and normal Male Wistar rats. </Comment>
    <BiopaxRef>cb4</BiopaxRef>
    <BiopaxRef>efc</BiopaxRef>
    <BiopaxRef>e04</BiopaxRef>
    <BiopaxRef>e84</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="UCP1" GraphId="eeb32" Type="Rna">
    <Comment>[Pubmed: 20183829] have shown that GAL stimulates GALR3 and induces downregulation of UCP1 in epididymal and subcutaneous fat tissues of high fat diet fed mouse.</Comment>
    <BiopaxRef>e2f</BiopaxRef>
    <Graphics FillColor="Transparent" FontStyle="Italic" Color="009900"/>
    </DataNode>
  <DataNode TextLabel="YAP1" GraphId="ea2f2" Type="Protein" GroupRef="f2837">
    <Comment>[Pubmed:28196718] have shown that GAL or M617 stimulates GALR1 and induces upregulation of YAP1 in Male Sprague-Dawley rats</Comment>
    <BiopaxRef>a25</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="CDKN1C" GraphId="b8794" Type="Protein" GroupRef="e5dde">
    <Comment>[Pubmed: 19276245] have shown that GAL stimulates GALR2 and induces upregulation of CDKN1C in serum starved UM-SCC-1-GALR2 cells with mutant p53.</Comment>
    <BiopaxRef>d9a</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="PRKCD" GraphId="a21cc" Type="Rna">
    <Comment>[Pubmed: 20183829] have shown that GAL stimulates GALR2 and induces upregulation of PRKCD in epididymal and subcutaneous fat tissues of high fat diet fed mouse.</Comment>
    <BiopaxRef>e2f</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="PPARG" GraphId="aa50d" Type="Rna" GroupRef="cdf7b">
    <Comment>[Pubmed: 20183829] have shown that GAL stimulates GALR1 and GALR2 and induces upregulation of PPARG in epididymal and subcutaneous fat tissues of high fat diet fed mouse.</Comment>
    <BiopaxRef>e2f</BiopaxRef>
    <Graphics FillColor="Transparent" FontStyle="Italic" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="Go alpha 2" GraphId="eeaf8">
        </DataNode>
  <DataNode TextLabel="POMC" GraphId="d71ee" Type="Protein" GroupRef="fdad2">
    <Comment>[Pubmed:19272414]have shown that GAL stimulates GALR1 and induces downregulation of POMC in C57BL6/J mice.</Comment>
    <BiopaxRef>d71</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="009900"/>
    </DataNode>
  <DataNode TextLabel="SLC2A4" GraphId="f8492" Type="Protein">
    <Comment>[Pubmed: 27041232] have shown that M617 stimulates GALR1 and induces the transport of SLC2A4 from cytoplasm to plasma membrane in skeletal muscle of diabetic rat</Comment>
    <BiopaxRef>cb4</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="IL6" GraphId="f5ccc" Type="Protein" GroupRef="b1f55">
    <Comment>[Pubmed:24568968] have shown that GAL stimulates GALR2 and induces the upregulation of IL6 in  UM-SCC-1 and UM-SCC-81B SSCHN cell lines.</Comment>
    <BiopaxRef>af8</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="ADIPOQ" GraphId="b9bfe" Type="Protein" GroupRef="ef24f">
    <Comment>[Pubmed:27127795] have shown that  M617 stimulates GALR1 and induces upregulation of ADIPOQ in Male Wistar Rat adipocytes.</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>df7</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="PPARGC1A" GraphId="f8a63" Type="Rna">
    <Comment>[Pubmed: 20183829] have shown that GAL stimlates GALR3 and induces downregulation of PPARGC1A in epididymal and subcutaneous fat tissues in high fat diest fed mouse.</Comment>
    <BiopaxRef>e2f</BiopaxRef>
    <Graphics FillColor="Transparent" FontStyle="Italic" Color="009900"/>
    </DataNode>
  <DataNode TextLabel="BCL2L11" GraphId="ac680" Type="Protein" GroupRef="d885b">
    <Comment>[Pubmed:24168112] have shown that  GAL stimulates GALR2  and induces upregulation of BCL211 in HEp-2 cell line.</Comment>
    <BiopaxRef>bd1</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="Increase in plasmacorticosteronelevels" GraphId="b1e66" Type="Metabolite" GroupRef="fdad2">
    <Comment>[Pubmed: 17982695] have shown that&#160;GAL stimulates GALR1 and induces the upregulation of cortisol in human adrenocortical cells. </Comment>
    <Comment>[Pubmed: 17143559] have shown that GAL stimulates GALR1 and GALR2 and&#160;induces the upregulation of corticosterone in&#160; rat adrenal zona fasciculatoreticularis cells in an adenylyl cyclase and PKA dependent manner.</Comment>
    <BiopaxRef>cea</BiopaxRef>
    <BiopaxRef>c33</BiopaxRef>
    <Graphics ShapeType="RoundedRectangle" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="VEGFA" GraphId="fa1a8" Type="Protein" GroupRef="b1f55">
    <Comment>[Pubmed:24568968] have shown that GAL stimulates GALR2 and induces the upregulation of VEGFA in  UM-SCC-1 and UM-SCC-81B SSCHN cell lines.</Comment>
    <BiopaxRef>af8</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="VAMP2" GraphId="a757a" Type="Protein" GroupRef="ef24f">
    <Comment>[Pubmed:27410235] have shown that M617 stimulates GALR1 and induces upregulation of VAMP2 in diabetic rats.</Comment>
    <BiopaxRef>e84</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="Increase in cAMP production" GraphId="fd921" Type="Metabolite" GroupRef="d2014">
    <BiopaxRef>cea</BiopaxRef>
    <Graphics ShapeType="RoundedRectangle" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CDKN1A" GraphId="c32fa" Type="Protein" GroupRef="a04b5">
    <Comment>[Pubmed:18272487] have shown that GAL stimulates GALR2 and induces downregulation of CDKN1A in PC12-GALR2 transfected cells.</Comment>
    <BiopaxRef>a96</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="Increase in bloodglucose level" GraphId="fdef9" Type="Metabolite" GroupRef="b4a4f">
    <Comment>[Pubmed:25690510] have shown that NAX-5055 stimulates GALR1 and induces an increase in blood glucose levels in CF-1 mice</Comment>
    <Comment>[Pubmed: 22308501] have shown that GAL stimualtes GALR1 and induces an increase in blood glucose levels in WT via Go2 signaling</Comment>
    <Comment>[Pubmed:25449850] have shown that M617 stimulates GALR1 and induces decrease in glucose levels in diabetic and normal male Wistar rats.</Comment>
    <BiopaxRef>efc</BiopaxRef>
    <BiopaxRef>a94</BiopaxRef>
    <BiopaxRef>e04</BiopaxRef>
    <Graphics ShapeType="RoundedRectangle" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="PPARG" GraphId="ee73a" Type="Protein" GroupRef="a2009">
    <Comment>[Pubmed: 27410235] have shown that M617 stimulates GALR1 and induces upregulation of PPARG in diabetic rats.</Comment>
    <BiopaxRef>e84</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="Secretion of chlorine" GraphId="a5a17" Type="Metabolite" GroupRef="f6238">
    <Comment>[Pubmed:9928160] have shown that GAL stimulates GALR1 and induces increase in Cl&#175; levels in T84 cells.</Comment>
    <BiopaxRef>a97</BiopaxRef>
    <Graphics ShapeType="RoundedRectangle" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="TFAP2A" GraphId="fdbc0" Type="Rna" GroupRef="cdf7b">
    <Comment>[Pubmed: 20183829] have shown that GAL stimulates GALR1 and GALR2 and induces upregulation of TFAP2A in epididymal and subcutaneous fat tissues of high fat diet fed mouse.</Comment>
    <BiopaxRef>e2f</BiopaxRef>
    <Graphics FillColor="Transparent" FontStyle="Italic" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="CDKN1B" GraphId="fb2f0" Type="Protein" GroupRef="e1fcf">
    <Comment>[Pubmed: 19276245] have shown that GAL stimulates GALR2 and induces upregulation of CDNK1B in serum starved UM-SCC-1-GALR2 cells with mutant p53 gene.</Comment>
    <BiopaxRef>d9a</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="CDKN1C" GraphId="a2c23" Type="Protein" GroupRef="e1fcf">
    <Comment>[Pubmed: 19276245] have shown that GAL stimulates GALR2 and induces upregulation of CDKN1C in serum starved UM-SCC-1-GALR2 cells with mutant p53.</Comment>
    <BiopaxRef>d9a</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="Increase in plasmacorticosteronelevels" GraphId="e496f" Type="Metabolite" GroupRef="d2014">
    <Comment>[Pubmed: 17143559] have shown that GAL stimulates GALR1 and GALR2 and&#160;induces the upregulation of corticosterone in&#160; rat adrenal zona fasciculatoreticularis cells in an adenylyl cyclase and PKA dependent manner.</Comment>
    <BiopaxRef>cea</BiopaxRef>
    <Graphics ShapeType="RoundedRectangle" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Increase in cAMP production" GraphId="e03fb" Type="Metabolite" GroupRef="f9e28">
    <BiopaxRef>cea</BiopaxRef>
    <Graphics ShapeType="RoundedRectangle" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Increase in plasmacorticosteronelevels" GraphId="d8a22" Type="Metabolite" GroupRef="f9e28">
    <Comment>[Pubmed: 17143559] have shown that GAL stimulates GALR1 and GALR2 and&#160;induces the upregulation of corticosterone in&#160; rat adrenal zona fasciculatoreticularis cells in an adenylyl cyclase and PKA dependent manner.</Comment>
    <BiopaxRef>cea</BiopaxRef>
    <Graphics ShapeType="RoundedRectangle" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CREB1" GraphId="a9ba4" Type="Protein" GroupRef="b40a1">
    <BiopaxRef>b77</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="SLC2A4" GraphId="b3b3d" Type="Protein" GroupRef="ec43a">
    <Comment>[Pubmed:27127795] have shown that  M617 stimulates GalR1 and induces upregulation of  SLC2A4 in total cell membrane and plasma membrane fractions of Male Wistar Rats adipocytes.</Comment>
    <Comment>[Pubmed:27410235] have shown that M617 stimulates GALR1 and induces upregulation of SLC2A4 in plasma membrane of myocytes in diabetic rats.</Comment>
    <Comment>[Pubmed: 27041232] have shown that M617 stimulates GALR1 and induces upregulation of SLC2A4 in plasma membranes of skeletal muscles in diabetic rats.</Comment>
    <BiopaxRef>df7</BiopaxRef>
    <BiopaxRef>e84</BiopaxRef>
    <BiopaxRef>cb4</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="PPARG" GraphId="e4076" Type="Rna">
    <Comment>[Pubmed: 20183829] have shown that GAL stimulates GALR1 and GALR2 and induces upregulation of PPARG in epididymal and subcutaneous fat tissues of high fat diet fed mouse.</Comment>
    <BiopaxRef>e2f</BiopaxRef>
    <Graphics FillColor="Transparent" FontStyle="Italic" Color="660066"/>
    </DataNode>
  <DataNode TextLabel="CDKN1B" GraphId="a33c7" Type="Protein" GroupRef="e5dde">
    <Comment>[Pubmed: 19276245] have shown that GAL stimulates GALR2 and induces upregulation of CDNK1B in serum starved UM-SCC-1-GALR2 cells with mutant p53 gene.</Comment>
    <BiopaxRef>d9a</BiopaxRef>
    <Graphics FillColor="Transparent" ShapeType="RoundedRectangle" Color="660066"/>
    </DataNode>
  <Interaction GraphId="idebc93d1e" GroupRef="ef24f">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="c8768"/>
      <Point/>
      <Point GraphRef="b9bfe" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id13114cb1" GroupRef="ef24f">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="e5a91"/>
      <Point GraphRef="fabbb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id6eb549aa" GroupRef="f6238">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a5a17"/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb3380e97" GroupRef="f6238">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="fb597"/>
      <Point/>
      <Point GraphRef="a5a17" ArrowHead="mim-modification"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id2f523655" GroupRef="b4a4f">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="eeaf8"/>
      <Point/>
      <Point GraphRef="fdef9" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idaa72960" GroupRef="ef24f">
    <Graphics LineStyle="Broken">
      <Point GraphRef="e1e37"/>
      <Point GraphRef="be028" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd79bbbac" GroupRef="f2837">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="dd377"/>
      <Point GraphRef="ca5d9" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idba00e5a2" GroupRef="ef24f">
    <Graphics Color="ff00ff">
      <Point GraphRef="be028"/>
      <Point GraphRef="f8492" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id9b605241">
    <Graphics LineStyle="Broken">
      <Point GraphRef="bcac4"/>
      <Point GraphRef="e6ff9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id2ab71f00" GroupRef="dca84">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="ef324"/>
      <Point GraphRef="b5135" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ida6d5075a">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d5fbe"/>
      <Point GraphRef="feeb2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8cec28ca">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b8e07" ArrowHead="Arrow"/>
      <Point GraphRef="f2c9d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id586bdf60">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a21cc"/>
      <Point GraphRef="ab537" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide6b31adb" GroupRef="d885b">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="00cccc">
      <Point GraphRef="a725f"/>
      <Point/>
      <Point GraphRef="e8612" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id7cfbb0f7" GroupRef="e5dde">
    <Graphics>
      <Point GraphRef="dd377"/>
      <Point GraphRef="d2de3" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide11c570f" GroupRef="dca84">
    <Graphics LineStyle="Broken">
      <Point GraphRef="e274d"/>
      <Point GraphRef="ef324" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ida737f653" GroupRef="ca2d4">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd10e5cee" GroupRef="a60a3">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="a725f"/>
      <Point/>
      <Point GraphRef="bcac2" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idde4766d0" GroupRef="b4a4f">
    <Graphics LineStyle="Broken">
      <Point GraphRef="fdef9"/>
      <Point GraphRef="bf559" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd8af63de">
    <Graphics ConnectorType="Elbow" Color="339900">
      <Point GraphRef="a725f"/>
      <Point/>
      <Point GraphRef="a4476" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf9759e74" GroupRef="b1f55">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="de22b"/>
      <Point GraphRef="f5ccc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8c7d7528" GroupRef="ef24f">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="a757a"/>
      <Point GraphRef="be028" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id29168ee6" GroupRef="a04b5">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d73ca"/>
      <Point GraphRef="c32fa" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id21204572">
    <Graphics LineStyle="Broken">
      <Point GraphRef="e620d" ArrowHead="Arrow"/>
      <Point GraphRef="a4476"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf96f4247">
    <Graphics LineStyle="Broken">
      <Point/>
      <Point GraphRef="eb906" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id934e45a9" GroupRef="a04b5">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d73ca"/>
      <Point GraphRef="bfcf2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idc60b0c05" GroupRef="ef24f">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="0033cc">
      <Point GraphRef="fb597"/>
      <Point/>
      <Point GraphRef="d7eeb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idccb0469c" GroupRef="f2837">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ca5d9"/>
      <Point GraphRef="e8a3b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id35d8c621" GroupRef="b40a1">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a9ba4"/>
      <Point GraphRef="f29b3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbc98bcd4" GroupRef="b1f55">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="de22b"/>
      <Point GraphRef="fa1a8" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide03b6180" GroupRef="d00eb">
    <Graphics Color="ff00ff">
      <Point GraphRef="c939a"/>
      <Point GraphRef="e68b7" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idcb7d366">
    <Graphics LineStyle="Broken" Color="ff0033">
      <Point GraphRef="e6ff9"/>
      <Point GraphRef="cbb8c" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ide1f8fbb" GroupRef="ef24f">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="ed53b"/>
      <Point/>
      <Point GraphRef="ae89f" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id4f597742" GroupRef="ab62a">
    <Graphics LineStyle="Broken" Color="0033cc">
      <Point GraphRef="cbb8c"/>
      <Point GraphRef="c7672" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e5635">
    <Graphics>
      <Point/>
      <Point GraphRef="bcac4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e24db" GroupRef="b33e7">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a4bf2" GroupRef="de7ad">
    <Graphics ConnectorType="Elbow" Color="339900">
      <Point GraphRef="a725f"/>
      <Point/>
      <Point GraphRef="f5d55" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="accfb" GroupRef="b1f55">
    <Graphics LineStyle="Broken" Color="0033cc">
      <Point GraphRef="c9435"/>
      <Point GraphRef="de22b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e49ba">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="c9435" ArrowHead="Arrow"/>
      <Point/>
      <Point/>
      <Point/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c1601" GroupRef="b1f55">
    <Graphics LineStyle="Broken" Color="0033cc">
      <Point GraphRef="de22b"/>
      <Point GraphRef="c1eb9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f1a5e" GroupRef="b1f55">
    <Graphics LineStyle="Broken">
      <Point GraphRef="c1eb9"/>
      <Point GraphRef="d30fa" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c6f6a" GroupRef="a60a3">
    <Graphics LineStyle="Broken">
      <Point GraphRef="bcac2"/>
      <Point GraphRef="dd8ed" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b16f1" GroupRef="a60a3">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="bcac2"/>
      <Point GraphRef="d8922" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d797d" GroupRef="b4a4f">
    <Graphics LineStyle="Broken">
      <Point GraphRef="eeaf8"/>
      <Point GraphRef="cdda1" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e12e5" GroupRef="f2837">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f2be5"/>
      <Point GraphRef="a21fa" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="de8b9" GroupRef="ca0e8">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff0033">
      <Point GraphRef="c8768"/>
      <Point GraphRef="dc84c" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e43d9" GroupRef="ca0e8">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d90b0"/>
      <Point GraphRef="cfb0e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a9b7c" GroupRef="e5dde">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d2de3"/>
      <Point GraphRef="e74f2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cac1c" GroupRef="ca0e8">
    <Graphics LineStyle="Broken">
      <Point GraphRef="dc84c"/>
      <Point GraphRef="cfb0e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8d6b" GroupRef="fdad2">
    <Graphics LineStyle="Broken">
      <Point GraphRef="aa167"/>
      <Point GraphRef="f5c95" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d2c5e" GroupRef="ef24f">
    <Graphics LineStyle="Broken" Color="0033cc">
      <Point GraphRef="d7eeb"/>
      <Point GraphRef="e1e37" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cf803" GroupRef="ef24f">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b9bfe"/>
      <Point GraphRef="fabbb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fafdd" GroupRef="ef24f">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ae89f"/>
      <Point GraphRef="fabbb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b952b" GroupRef="f2837">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ea2f2"/>
      <Point GraphRef="e8a3b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0fb4" GroupRef="f2837">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="0033cc">
      <Point GraphRef="dd377"/>
      <Point GraphRef="f2be5" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="db242" GroupRef="dca84">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ef324"/>
      <Point GraphRef="fd87f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f21e8" GroupRef="d00eb">
    <Graphics Color="ff00ff">
      <Point ArrowHead="Arrow"/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f50dd" GroupRef="cdf7b">
    <Graphics LineStyle="Broken" Color="0033cc">
      <Point GraphRef="a33e4"/>
      <Point GraphRef="c125f" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ccc5a" GroupRef="cdf7b">
    <Graphics LineStyle="Broken" Color="0033cc">
      <Point GraphRef="c125f"/>
      <Point GraphRef="ab537" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fe4e7" GroupRef="d885b">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ac680"/>
      <Point GraphRef="eeca3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a4668" GroupRef="fdad2">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="33ffff">
      <Point GraphRef="fb597"/>
      <Point/>
      <Point GraphRef="aa167" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b6f44" GroupRef="fdad2">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="ed53b"/>
      <Point/>
      <Point GraphRef="d71ee" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f23f7" GroupRef="fdad2">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d71ee"/>
      <Point GraphRef="f5c95" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fc8dc" GroupRef="a60a3">
    <Graphics LineStyle="Broken">
      <Point GraphRef="dd8ed"/>
      <Point GraphRef="eed21" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="afc5c" GroupRef="a60a3">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d8922"/>
      <Point GraphRef="f82b7" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c17fd" GroupRef="ef24f">
    <Graphics Color="ff00ff">
      <Point ArrowHead="Arrow"/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="db3b6" GroupRef="ef24f">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="0033cc">
      <Point GraphRef="fb597"/>
      <Point/>
      <Point GraphRef="c6e42" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d1ff5" GroupRef="ef24f">
    <Graphics LineStyle="Broken">
      <Point GraphRef="c6e42"/>
      <Point GraphRef="a757a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ff3cc" GroupRef="b1f55">
    <Graphics LineStyle="Broken">
      <Point GraphRef="fa1a8"/>
      <Point GraphRef="d30fa" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ba576" GroupRef="b1f55">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f5ccc"/>
      <Point GraphRef="d30fa" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8658" GroupRef="b4aea">
    <Graphics LineStyle="Broken" Color="0033cc">
      <Point GraphRef="e620d"/>
      <Point GraphRef="a5b59" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d55b1" GroupRef="b4aea">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a5b59"/>
      <Point GraphRef="a3155" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c44e7" GroupRef="a04b5">
    <Graphics LineStyle="Broken">
      <Point GraphRef="c32fa"/>
      <Point GraphRef="bbcbb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c2a88" GroupRef="e5dde">
    <Graphics LineStyle="Broken" Color="0033cc">
      <Point GraphRef="eb906"/>
      <Point GraphRef="dd377" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b7bfd" GroupRef="e5dde">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="dd377"/>
      <Point GraphRef="b8794" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f8df8" GroupRef="e5dde">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a33c7"/>
      <Point GraphRef="e74f2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d9d4d" GroupRef="e5dde">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b8794"/>
      <Point GraphRef="e74f2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="afe5b" GroupRef="e1fcf">
    <Graphics LineStyle="Broken">
      <Point GraphRef="c9b1c"/>
      <Point GraphRef="ffe0f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ca00a" GroupRef="e1fcf">
    <Graphics LineStyle="Broken" Color="0033cc">
      <Point GraphRef="f2c9d"/>
      <Point GraphRef="f03b1" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b21f5" GroupRef="e1fcf">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="f03b1"/>
      <Point GraphRef="fb2f0" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d748b" GroupRef="e1fcf">
    <Graphics LineStyle="Broken">
      <Point GraphRef="fb2f0"/>
      <Point GraphRef="ffe0f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bf6ed" GroupRef="e1fcf">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a2c23"/>
      <Point GraphRef="ffe0f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e0ca0" GroupRef="dca84">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b5135"/>
      <Point GraphRef="a403d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec701" GroupRef="fdad2">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d6ef9"/>
      <Point GraphRef="b1e66" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dc5fe" GroupRef="b4a4f">
    <Graphics LineStyle="Broken">
      <Point GraphRef="cdda1"/>
      <Point GraphRef="bf559" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fb707" GroupRef="fdad2">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b1e66"/>
      <Point GraphRef="f5c95" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c28cf">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="bcac4"/>
      <Point GraphRef="eeb32" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cd395">
    <Graphics Color="339900">
      <Point GraphRef="a3bfe"/>
      <Point/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c1c3f">
    <Graphics ConnectorType="Elbow" Color="339900">
      <Point GraphRef="a3bfe"/>
      <Point/>
      <Point GraphRef="a02f4" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0879">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="fb597"/>
      <Point/>
      <Point GraphRef="c8768" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cd89d" GroupRef="ca0e8">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff0033">
      <Point GraphRef="c8768"/>
      <Point GraphRef="d90b0" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b2295" GroupRef="fdad2">
    <Graphics LineStyle="Broken">
      <Point GraphRef="e3274"/>
      <Point GraphRef="d6ef9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e7a2e" GroupRef="d2014">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d15dc"/>
      <Point GraphRef="e496f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bb485" GroupRef="d2014">
    <Graphics LineStyle="Broken">
      <Point GraphRef="e496f"/>
      <Point GraphRef="f8327" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bd2a3" GroupRef="d2014">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b8e07"/>
      <Point GraphRef="d15dc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f1be9" GroupRef="d2014">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="d15dc"/>
      <Point GraphRef="fd921" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="afae5" GroupRef="d2014">
    <Graphics LineStyle="Broken">
      <Point GraphRef="fd921"/>
      <Point GraphRef="f8327" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0c5b">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="e274d"/>
      <Point GraphRef="a53e9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e8032" GroupRef="a04b5">
    <Graphics LineStyle="Broken">
      <Point GraphRef="bfcf2"/>
      <Point GraphRef="bbcbb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8ff1" GroupRef="f9e28">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="eb906"/>
      <Point GraphRef="f4a91" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ff95b" GroupRef="f9e28">
    <Graphics LineStyle="Broken">
      <Point GraphRef="cccdd"/>
      <Point GraphRef="d8a22" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d3e93" GroupRef="f9e28">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d8a22"/>
      <Point GraphRef="c3ac2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cac68" GroupRef="f9e28">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f4a91"/>
      <Point GraphRef="cccdd" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b0b4c">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="cccdd"/>
      <Point/>
      <Point GraphRef="e03fb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f8d25">
    <Graphics LineStyle="Broken">
      <Point GraphRef="e03fb"/>
      <Point GraphRef="c3ac2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ida1b9b852" GroupRef="b40a1">
    <Graphics LineStyle="Broken" Color="ff0033">
      <Point GraphRef="d4635"/>
      <Point GraphRef="a9ba4" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e25e6">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="ed53b"/>
      <Point/>
      <Point GraphRef="eeaf8" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ebae6" GroupRef="f2837">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a21fa"/>
      <Point GraphRef="ea2f2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f9e89" GroupRef="a69e3">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b8ed3"/>
      <Point GraphRef="f6308" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f2d0b" GroupRef="a69e3">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="0033cc">
      <Point GraphRef="a725f"/>
      <Point/>
      <Point GraphRef="b8ed3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fd55d" GroupRef="a69e3">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="0033cc">
      <Point GraphRef="a725f"/>
      <Point/>
      <Point GraphRef="a09a8" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c582a" GroupRef="a69e3">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a09a8"/>
      <Point GraphRef="f6308" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cb778">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ee73a"/>
      <Point GraphRef="fabbb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cf514">
    <Graphics LineStyle="Broken">
      <Point GraphRef="aa50d"/>
      <Point GraphRef="ccc5e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cd421">
    <Graphics LineStyle="Broken">
      <Point GraphRef="fdbc0"/>
      <Point GraphRef="ccc5e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e5b73">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="0033cc">
      <Point GraphRef="a09a8"/>
      <Point GraphRef="bb8e1" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cec5e" GroupRef="ec43a">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="0033cc">
      <Point GraphRef="a725f"/>
      <Point/>
      <Point GraphRef="de9c4" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d5713" GroupRef="ec43a">
    <Graphics LineStyle="Broken" Color="0033cc">
      <Point GraphRef="de9c4"/>
      <Point GraphRef="d58ae" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d9798">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="0033cc">
      <Point GraphRef="a725f"/>
      <Point/>
      <Point GraphRef="b5a3b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="be0d3">
    <Graphics LineStyle="Broken">
      <Point GraphRef="c7672"/>
      <Point GraphRef="b7128" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b76f5">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="fb597"/>
      <Point/>
      <Point GraphRef="e3274" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f8646">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="ed53b"/>
      <Point/>
      <Point GraphRef="d763b" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idd634bb7b" GroupRef="e5dde">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="dd377"/>
      <Point GraphRef="a33c7" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id506d4739" GroupRef="cdf7b">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ab537"/>
      <Point GraphRef="aa50d" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b954e" GroupRef="cdf7b">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="eb906"/>
      <Point GraphRef="fdbc0" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a135a" GroupRef="e196b">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff0099">
      <Point GraphRef="fb597"/>
      <Point GraphRef="fda54" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bc7cb" GroupRef="e196b">
    <Graphics Color="ff00ff">
      <Point ArrowHead="Arrow"/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb20ff3e1" GroupRef="cdf7b">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="eb906"/>
      <Point GraphRef="a33e4" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idc6584a5a">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a53e9"/>
      <Point GraphRef="a21cc" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b918f">
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="ff0033">
      <Point GraphRef="a725f"/>
      <Point/>
      <Point GraphRef="d73ca" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e9bb3">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a4476"/>
      <Point GraphRef="e274d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e436a" GroupRef="de7ad">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f5d55"/>
      <Point GraphRef="f7b5e" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e801f" GroupRef="e1fcf">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f03b1"/>
      <Point GraphRef="c9b1c" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f8566" GroupRef="e1fcf">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="f03b1"/>
      <Point GraphRef="a2c23" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c4cf4">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b5a3b"/>
      <Point GraphRef="e4076" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ca0d4" GroupRef="ec43a">
    <Graphics LineStyle="Broken">
      <Point GraphRef="e4076"/>
      <Point GraphRef="b3b3d" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf7cafa0f" GroupRef="d885b">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ee14a"/>
      <Point GraphRef="ac680" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id53c5cfec">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="bcac4"/>
      <Point/>
      <Point GraphRef="f8a63" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GraphId="idc6719f54" GroupRef="bd62c">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="iddcdcad2d" GroupRef="d7a58">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f2b6c" GroupRef="d2f5a">
    <Graphics Color="00cc00">
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b5ebb" GroupRef="d7a58">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ff607" GroupRef="d7a58">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c2f37" GroupRef="f0ba0">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b8aac" GroupRef="f0ba0">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d82fa" GroupRef="f0ba0">
    <Graphics>
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e52bc" GroupRef="d082d">
    <Graphics Color="ff0000">
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e1fd1" GroupRef="d082d">
    <Graphics Color="ff0000">
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ef639" GroupRef="afdbd">
    <Graphics Color="00cccc">
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c8466" GroupRef="c4263">
    <Graphics Color="0033cc">
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b3be0" GroupRef="b84a9">
    <Graphics Color="ff00ff">
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ac51d" GroupRef="a379f">
    <Graphics Color="00cccc">
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a2fe0" GroupRef="e193c">
    <Graphics Color="ff00ff">
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e67e4">
    <Graphics>
      <Point/>
      <Point GraphRef="aba21"/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="PM" GraphId="b6213" GroupRef="d00eb">
    <Graphics FillColor="ffffff" Color="ff00ff"/>
  </Label>
  <Label TextLabel="CY" GraphId="f19f3" GroupRef="d00eb">
    <Graphics FillColor="ffffff" Color="ff00ff"/>
  </Label>
  <Label TextLabel="PM" GraphId="f3426">
    <Graphics FillColor="ffffff" Color="ff00ff"/>
  </Label>
  <Label TextLabel="CY" GraphId="f535e" GroupRef="ef24f">
    <Graphics FillColor="ffffff" Color="ff00ff"/>
  </Label>
  <Label TextLabel="Receptor" GraphId="aba21">
    <Graphics FillColor="ffffff" ShapeType="Rectangle"/>
  </Label>
  <Label TextLabel="Protein up-regulation" GraphId="af1c4">
    <Graphics ShapeType="RoundedRectangle" Color="660066"/>
  </Label>
  <Label TextLabel="Protein Activation" GraphId="d4f4f">
    <Graphics FillColor="ffffff" ShapeType="Oval" Color="006666"/>
  </Label>
  <Label TextLabel="mRNA up-regulation" GraphId="ee716">
    <Graphics FontStyle="Italic" ShapeType="Rectangle" Color="660066"/>
  </Label>
  <Label TextLabel="Phosphorylation site and residue" GraphId="e019c">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Ligand" GraphId="a690c">
    <Graphics FillColor="ffffff" ShapeType="Rectangle"/>
  </Label>
  <Label TextLabel="Induced activation and increases protein expression" GraphId="ebf1d">
    <Graphics FillColor="ffffff" Align="Left"/>
  </Label>
  <Label TextLabel="Inhibition" GraphId="d3c5d">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="Transport" GraphId="e0c27">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="Positive regulation of gene expression" GraphId="eebf2">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="Leads to through unknown mechanism" GraphId="ed56a">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="Negative regulation of gene expression" GraphId="e0d2e">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="Translocation " GraphId="a93fe">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="Protein-protein interaction" GraphId="c347d" GroupRef="d2f5a">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="Dephosphorylation" GraphId="b6788">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="LEGEND" GraphId="f9a3a">
    <Graphics FillColor="ffffff" FontName="SansSerif" Color="3333ff"/>
  </Label>
  <Label TextLabel="Phosphorylation" GraphId="f2d63">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="Nucleus" GraphId="b21a2">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="Cytoplasm" GraphId="f65f5">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="Plasma membrane" GraphId="ed78d">
    <Graphics FillColor="ffffff" FontName="SansSerif"/>
  </Label>
  <Label TextLabel="CY" GraphId="be6d5">
    <Graphics FillColor="ffffff" Color="ff00ff"/>
  </Label>
  <Label TextLabel="PM" GraphId="f73fe">
    <Graphics FillColor="ffffff" Color="ff00ff"/>
  </Label>
  <Label TextLabel="NU" GraphId="abfd6">
    <Graphics FillColor="ffffff" Color="ff00ff"/>
  </Label>
  <Label TextLabel="Protein" GraphId="adad7">
    <Graphics ShapeType="RoundedRectangle" Color="660066"/>
  </Label>
  <Label TextLabel="Protein down-regulation" GraphId="bc90a">
    <Graphics ShapeType="RoundedRectangle" Color="009900"/>
  </Label>
  <Label TextLabel="mRNA up-regulation" GraphId="b10dd">
    <Graphics FontStyle="Italic" ShapeType="Rectangle" Color="009900"/>
  </Label>
  <Label TextLabel="DNA binding" GraphId="df587">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="PM" GraphId="b183d" GroupRef="e196b">
    <Graphics FillColor="ffffff" Color="ff00ff"/>
  </Label>
  <Label TextLabel="NU" GraphId="a960b" GroupRef="e196b">
    <Graphics FillColor="ffffff" Color="ff00ff"/>
  </Label>
  <Shape GraphId="a08af" GroupRef="bd62c">
    <Graphics FillColor="000000" ShapeType="Triangle"/>
  </Shape>
  <Shape GraphId="d714e">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="e766a" GroupRef="ca2d4">
    <Graphics ShapeType="Arc"/>
  </Shape>
  <Shape TextLabel="Galanin receptor pathway" GraphId="b8fe2">
    <Graphics ShapeType="None"/>
  </Shape>
  <Shape TextLabel="DNA" GraphId="cebaa">
    <Graphics ShapeType="RoundedRectangle" LineStyle="Broken" Color="ff6600"/>
  </Shape>
  <Shape TextLabel="RAP1Bmediated" GraphId="c9435" GroupRef="b1f55">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape GraphId="b6949" GroupRef="d00eb">
    <Graphics ShapeType="Oval" LineStyle="Broken" Color="ff00ff"/>
  </Shape>
  <Shape TextLabel="&#10;&#10;&#10;&#10;&#10;&#10;         Nucleus&#10;" GraphId="d5fbe">
    <Graphics ShapeType="Oval" Color="666666"/>
  </Shape>
  <Shape TextLabel="IP accumulation" GraphId="ef324" GroupRef="dca84">
    <Comment>[Pubmed: 27592409] have shown that GAL stimulates GALR2 and induces an increase in inositol phosphate in a Gq dependent manner Chinese Hamster Ovary KI cells. </Comment>
    <Comment>[Pubmed: 21226711] have shown that galanin stimulates GALR2 and induces an increase in IP3 in rat microglial cells.</Comment>
    <BiopaxRef>c8b</BiopaxRef>
    <BiopaxRef>d22</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="Endoplasmic reticulum" GraphId="a169e" GroupRef="dca84">
    <Graphics ShapeType="Sarcoplasmic Reticulum" Color="666666"/>
  </Shape>
  <Shape GraphId="ebfea">
    <Graphics ShapeType="Arc"/>
  </Shape>
  <Shape GraphId="a338a" GroupRef="b33e7">
    <Graphics ShapeType="Arc"/>
  </Shape>
  <Shape GraphId="e7bf0" GroupRef="b33e7">
    <Comment>Type your comment here</Comment>
    <Comment>Type your comment here</Comment>
    <Graphics ShapeType="Oval" Color="ff3366"/>
  </Shape>
  <Shape TextLabel="GALR2" GraphId="a3bfe" GroupRef="ca2d4">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="GNAQ" GraphId="a4476" GroupRef="dca84">
    <Comment>[Pubmed:10980593] have shown that GAL stimulates GALR2 and induces activation of GNAQ in H69 and COS-7 cell lines.</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>c5c</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="GNAI1&#10;" GraphId="eb906">
    <Comment>[Pubmed:10980593] have shown that GAL stimulates GALR2 and induces activation of GNAI1 in H69 and COS-7 cell lines.
</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>c5c</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="GNA12&#10;" GraphId="f5d55" GroupRef="de7ad">
    <Comment>[Pubmed:10980593] have shown that GAL stimulates GALR2 and induces activation of GNA12 in H69 and COS-7 cell lines.
</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>c5c</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="e8612" GroupRef="d885b">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK1" GraphId="cbd5f" GroupRef="d885b">
    <Comment>[Pubmed: 24168112] have shown that GAL stimulates GALR2 receptor and induces dephosphorylation of MAPK1 in HEp-2 and KB cell lines.
</Comment>
    <BiopaxRef>bd1</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK3" GraphId="ee14a" GroupRef="d885b">
    <Comment>[Pubmed: 24168112] have shown that GAL stimulates GALR2 receptor and induces dephosphorylation of MAPK3 in HEp-2 and KB cell lines.
</Comment>
    <BiopaxRef>bd1</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="Y204" GraphId="a2cb6" GroupRef="d885b">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T202" GraphId="b5f01" GroupRef="d885b">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="MAPK14" GraphId="de22b" GroupRef="b1f55">
    <Comment>[Pubmed:24568968]have shown that GAL stimulates GALR2 and induces phosphorylation of MAPK14 at Thr 180 and Tyr 182 in UM-SCC-1 and UM-SCC-81B SSCHN cell lines and pcDNA control cells.
</Comment>
    <BiopaxRef>af8</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="Y182" GraphId="b8a61" GroupRef="b1f55">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T180" GraphId="d196d">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="ZFP36" GraphId="c1eb9" GroupRef="b1f55">
    <Comment>[Pubmed:24568968] have shown that GAL stimulates GALR2 and induces phosphorylation of ZFP36 in UM-SCC-1 cell line.</Comment>
    <BiopaxRef>af8</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="Y182" GraphId="a08a5" GroupRef="b1f55">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="Induces angiogenesis " GraphId="d30fa" GroupRef="b1f55">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="TERF2IP&#10;" GraphId="bcac2" GroupRef="a60a3">
    <Graphics FillColor="ffffff" ShapeType="Oval" Color="006666"/>
  </Shape>
  <Shape TextLabel="GTP&#10;" GraphId="d6c6e" GroupRef="a60a3">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape GraphId="dd8ed" GroupRef="a60a3">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK1" GraphId="a21cf" GroupRef="a60a3">
    <Comment>[Pubmed: 21345369] have shown that GAL stimulates GALR1 and induces phosphorylation of MAPK1 mediated by Rap1 in UM-SCC-1 cell line</Comment>
    <BiopaxRef>f41</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK3" GraphId="d1bed" GroupRef="a60a3">
    <Comment>[Pubmed: 21345369] have shown that GAL stimulates GALR1 and induces phosphorylation of MAPK3 mediated by Rap1 in UM-SCC-1 cell line</Comment>
    <BiopaxRef>f41</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="AKT1" GraphId="d8922" GroupRef="a60a3">
    <Comment>[Pubmed: 21345369] have shown that GAL stimulates GALR2 and induces phosphorylation of AKT1 at Ser473 mediated by Rap1 in UM-SCC-1 and OSSC 3 cell lines.</Comment>
    <BiopaxRef>f41</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="CREB1" GraphId="c7672" GroupRef="ab62a">
    <Comment>[Pubmed: 20183829] have shown that GAL stimulates GALR2 and induces phosphorylation of CREB1 on Ser at 133 in epididymal and subcutaneous fat tissues. </Comment>
    <BiopaxRef>e2f</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="S133&#10;&#10;" GraphId="bbfae">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="TBC1D4" GraphId="e1e37" GroupRef="ef24f">
    <BiopaxRef>df7</BiopaxRef>
    <BiopaxRef>cb4</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="T642" GraphId="c8369" GroupRef="ef24f">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="Induces adipogenesis and adipocyte differentiation" GraphId="feeb2">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="RPS6KA1" GraphId="f2be5" GroupRef="f2837">
    <Comment>[Pubmed:28196718] have shown that GAL(1-29) or M617 stimulates GALR1 receptor and induces phosphorylation of RPS6KA1 in total liver extracts of Sprague Dawley rats and mouse cholangiocyte cell lines. </Comment>
    <BiopaxRef>a25</BiopaxRef>
    <Graphics FillColor="ffffff" ShapeType="Oval" Color="006666"/>
  </Shape>
  <Shape TextLabel="Proliferation of cholangiocytes" GraphId="e8a3b" GroupRef="f2837">
    <Graphics FillColor="ffffff" ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="CASP3&#10;" GraphId="bfcf2" GroupRef="a04b5">
    <Comment>[Pubmed:10980593] have shown that GAL stimulates GALR2 and induces activation of GNA12 in H69 and COS-7 cell lines.</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>d9a</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="CASP8" GraphId="dc84c" GroupRef="ca0e8">
    <Comment>[Pubmed:28203483] have shown that GAL stimulates GALR1 and induces CASP3 inhibition in MCAO Mice.</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>cdf</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="CASP12" GraphId="d90b0" GroupRef="ca0e8">
    <Comment>[Pubmed:28203483] have shown that GAL stimulates GALR1 and induces CASP3 inhibition in MCAO Mice.</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>cdf</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel=" Induces apoptosis,&#10;Inbihits cell growth" GraphId="cfb0e" GroupRef="ca0e8">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape GraphId="dd377" GroupRef="e5dde">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK1" GraphId="a46e5" GroupRef="e5dde">
    <Comment>[Pubmed:25017118] have shown that GAL stimulates GALR2  induces phosphorylation of MAPK1 at Thr 185 and Tyr at 187 in UM-SCC-1 cell lines in G&#945;&#7522; dependent manner</Comment>
    <BiopaxRef>bfe</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK3" GraphId="fa33d" GroupRef="e5dde">
    <Comment>[Pubmed:25017118] have shown that GAL stimulates GALR2  induces phosphorylation of MAPK3 at Thr 202 and Tyr 204 in UM-SCC-1 cell lines in G&#945;&#7522; dependent manner</Comment>
    <BiopaxRef>bfe</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="CCND1" GraphId="d2de3" GroupRef="e5dde">
    <Comment>[Pubmed:25017118] have shown that GAL stimulates GALR2 and induces the downregulation of CCND1 in UM-SCC-1 cell lines.</Comment>
    <Comment>[Pubmed: 19276245] have shown that  GAL stimulates GALR2 and induces downregulation of serum starved CCND1 in UM-SCC-1-GALR2 with mutant p53 gene. </Comment>
    <BiopaxRef>bfe</BiopaxRef>
    <BiopaxRef>d9a</BiopaxRef>
    <Graphics ShapeType="RoundedRectangle" Color="009900"/>
  </Shape>
  <Shape TextLabel="Inhibits proliferation" GraphId="e74f2" GroupRef="e5dde">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="Regulates glucosehomeostasis" GraphId="bf559" GroupRef="b4a4f">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel=" RHOA" GraphId="f7b5e" GroupRef="de7ad">
    <Graphics FillColor="ffffff" ShapeType="Oval" Color="006666"/>
  </Shape>
  <Shape TextLabel="KCNMA1" GraphId="b5135" GroupRef="dca84">
    <Comment>[Pubmed:24602615] have shown that GAL and AR-M1896 stimulates GALR2 and induces activation of KCNMA1 mediated by Ca2+ efflux from the SR/ER in HEK293 cell line.</Comment>
    <BiopaxRef>b06</BiopaxRef>
    <Graphics FillColor="ffffff" ShapeType="Oval" Color="006666"/>
  </Shape>
  <Shape TextLabel="AKT1" GraphId="d7eeb" GroupRef="ef24f">
    <BiopaxRef>edd</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="S473&#10;" GraphId="dd9b5" GroupRef="ef24f">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="Ameliorate insulin resistance" GraphId="fabbb" GroupRef="ef24f">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="Ca2+ efflux&#10;" GraphId="fd87f" GroupRef="dca84">
    <Comment>[Pubmed:24602615] have shown that AR-M1896 stimulates GALR2 and induces an increase in intracellular Ca2+ which activates KCNMA1 in HEK293 cell line</Comment>
    <BiopaxRef>b06</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="PLC" GraphId="e274d" GroupRef="dca84">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="GALR2" GraphId="c939a" GroupRef="d00eb">
    <Comment>[Pubmed:15471987] have shown that GAL stimulates GALR2 and induces the transport of GALR2 from plasma membrane to the cytoplasm in PC12 cells.</Comment>
    <Comment>[Pubmed: 15885774] have shown that GAL stimulates GALR2 and induces the transport of GALR2 from plasma membrane to the cytoplasm in PC12 cells.</Comment>
    <BiopaxRef>d0c</BiopaxRef>
    <BiopaxRef>f61</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="GALR2" GraphId="e68b7" GroupRef="d00eb">
    <Comment>[Pubmed: 15885774] have shown that GAL stimulates GALR2 and induces the transport of GALR2 from plasma membrane to the cytoplasm in PC12 cells. </Comment>
    <Comment>[Pubmed:15471987] have shown that GAL stimulates GALR2 and induces the transport of GALR2 from plasma membrane to the cytoplasm in PC12 cells.</Comment>
    <BiopaxRef>d0c</BiopaxRef>
    <BiopaxRef>f61</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="&#10;NRAS" GraphId="a33e4" GroupRef="cdf7b">
    <BiopaxRef>e2f</BiopaxRef>
    <Graphics FontStyle="Italic" ShapeType="Rectangle" Color="660066"/>
  </Shape>
  <Shape TextLabel="RAF1" GraphId="c125f" GroupRef="cdf7b">
    <BiopaxRef>e2f</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="S259&#10;" GraphId="c53c6" GroupRef="cdf7b">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape GraphId="ab537" GroupRef="cdf7b">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK1" GraphId="d4b54" GroupRef="cdf7b">
    <Comment>[Pubmed: 20183829] have shown that GAL induces phosphorylation of MAPK1 at Thr 185 and Tyr at 187 in epididymal and subcutaneous fat tissue of high fat diet mouse fat tissue.</Comment>
    <Comment>[Pubmed: 16819983] have shown that GAL or GALP stimulates GALR2 and induces phosphorylation of MAPK1 in human PC12 cell lines in a PKC dependent manner.</Comment>
    <BiopaxRef>e2f</BiopaxRef>
    <BiopaxRef>c91</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK3" GraphId="a511c" GroupRef="cdf7b">
    <Comment>[Pubmed: 20183829] have shown that GAL induces phosphorylation of MAPK3 at Thr at 202 and Tyr at 204 in epididymal and subcutaneous fat tissue of high fat diet mouse fat tissue.</Comment>
    <Comment>[Pubmed: 16819983] have shown that GAL or GALP stimulates GALR2 and induces phosphorylation of MAPK3 in human PC12 cell lines in a PKC dependent manner.</Comment>
    <BiopaxRef>e2f</BiopaxRef>
    <BiopaxRef>c91</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="f12d9" GroupRef="ca2d4">
    <Graphics ShapeType="Oval" Color="ff3366"/>
  </Shape>
  <Shape GraphId="e45a0">
    <Graphics ShapeType="Oval" Color="ff3366"/>
  </Shape>
  <Shape TextLabel=" Induces cell proliferation" GraphId="eed21" GroupRef="a60a3">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="Induces cell survival" GraphId="f82b7" GroupRef="a60a3">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="Y204" GraphId="b5691" GroupRef="a60a3">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="Y187" GraphId="cb642" GroupRef="a60a3">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T202" GraphId="a6b07" GroupRef="a60a3">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T185" GraphId="d53c8" GroupRef="a60a3">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="S473&#10;" GraphId="b7c78" GroupRef="a60a3">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape GraphId="e5a91" GroupRef="ef24f">
    <Graphics ShapeType="Oval" LineStyle="Broken" Color="ff00ff"/>
  </Shape>
  <Shape TextLabel="AKT1" GraphId="c6e42" GroupRef="ef24f">
    <BiopaxRef>edd</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="T308" GraphId="bde6c" GroupRef="ef24f">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape GraphId="a5b59" GroupRef="b4aea">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="Y204" GraphId="c79f4" GroupRef="b4aea">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="MAPK1" GraphId="fc0da" GroupRef="b4aea">
    <Comment>[Pubmed:23897649] have shown that  AR-M1896 stimulates GALR2  and induces the phosphorylation of MAPK1 Thr 185 and Tyr at 187 in cholinergic neurons from mouse fetal forebrain</Comment>
    <BiopaxRef>b9c</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK3" GraphId="ca3ff" GroupRef="b4aea">
    <Comment>[Pubmed:23897649] have show that  AR-M1896 stimulates GALR2  and induces the phosphorylation of MAPK3 at Thr at 202 and Tyr at 204 in cholinergic neurons from mouse fetal forebrain.</Comment>
    <BiopaxRef>b9c</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="Y187" GraphId="df414" GroupRef="b4aea">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T202" GraphId="d8afc" GroupRef="b4aea">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T185" GraphId="a75ca" GroupRef="b4aea">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="Modulates morphological changes in cholinergicneurons&#10;" GraphId="a3155" GroupRef="b4aea">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="PI3K/AKT pathway" GraphId="d73ca" GroupRef="a04b5">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel=" Induces apoptosis" GraphId="bbcbb" GroupRef="a04b5">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="Y204" GraphId="ef6a6" GroupRef="e5dde">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="Y187" GraphId="d134d" GroupRef="e5dde">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T202" GraphId="e13cb" GroupRef="e5dde">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T185" GraphId="e7c48" GroupRef="e5dde">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="GNAI1&#10;" GraphId="f2c9d" GroupRef="e1fcf">
    <Comment>[Pubmed:10980593] have shown that GAL stimulates GALR2 and induces activation of GNAI1 in H69 and COS-7 cell lines.</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>c5c</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="f03b1" GroupRef="e1fcf">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK1" GraphId="d839f" GroupRef="e1fcf">
    <Comment>[Pubmed:25017118] have shown that GAL stimulates GALR2  induces phosphorylation of MAPK1 at Thr 185 and Tyr at 187 in UM-SCC-1 cell lines in G&#945;&#7522; dependent manner</Comment>
    <BiopaxRef>bfe</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="MAPK3" GraphId="cfd45" GroupRef="e1fcf">
    <Comment>[Pubmed:25017118] have shown that GAL stimulates GALR2  induces phosphorylation of MAPK3 at Thr 202 and Tyr 204 in UM-SCC-1 cell lines in G&#945;&#7522; dependent manner</Comment>
    <BiopaxRef>bfe</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="&#10;CCND1" GraphId="c9b1c" GroupRef="e1fcf">
    <Comment>[Pubmed:25017118] have shown that GAL stimulates GALR2 and induces the downregulation of CCND1 in UM-SCC-1 cell lines.</Comment>
    <Comment>[Pubmed: 19276245] have shown that  GAL stimulates GALR2 and induces downregulation of serum starved CCND1 in UM-SCC-1-GALR2 with mutant p53 gene.</Comment>
    <BiopaxRef>bfe</BiopaxRef>
    <BiopaxRef>d9a</BiopaxRef>
    <Graphics ShapeType="RoundedRectangle" Color="009900"/>
  </Shape>
  <Shape TextLabel="Inhibits cell proliferation" GraphId="ffe0f" GroupRef="e1fcf">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="Y204" GraphId="de63d" GroupRef="e1fcf">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="Y187" GraphId="b8f36" GroupRef="e1fcf">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T202" GraphId="f928e" GroupRef="e1fcf">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T185" GraphId="f1d3e" GroupRef="e1fcf">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="Role in neuro-&#10;transmitter release and cellular excitability " GraphId="a403d" GroupRef="dca84">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="Cl-" GraphId="ee321" GroupRef="f6238">
    <Graphics ShapeType="Oval"/>
  </Shape>
  <Shape TextLabel="Cl-" GraphId="cf10d" GroupRef="f6238">
    <Graphics ShapeType="Oval"/>
  </Shape>
  <Shape TextLabel="Cl-" GraphId="f2dfb" GroupRef="f6238">
    <Graphics ShapeType="Oval"/>
  </Shape>
  <Shape TextLabel=" Induces apoptosis,&#10;Inbihits cell growth" GraphId="eeca3" GroupRef="d885b">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="Stress and pain modulation" GraphId="f5c95" GroupRef="fdad2">
    <Graphics FillColor="ffffff" ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="PKA dependent" GraphId="d6ef9" GroupRef="fdad2">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel="&#10;&#10;&#10;&#10;&#10;                 Nucleus" GraphId="bc1fa">
    <Graphics ShapeType="Oval" Color="666666"/>
  </Shape>
  <Shape TextLabel="GNAI1&#10;" GraphId="e6ff9">
    <Comment>[Pubmed:10980593] have shown that GAL stimulates GALR2 and induces activation of GNAI1 in H69 and COS-7 cell lines.</Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>c5c</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="Adenylyl cyclase" GraphId="cbb8c">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel="CREB1" GraphId="b7128">
    <Comment>[Pubmed: 20183829] have shown that GAL stimulates GALR2 and induces phosphorylation of CREB1 on Ser at 133 in epididymal and subcutaneous fat tissues.</Comment>
    <BiopaxRef>e2f</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="PRKCGmediated" GraphId="c8768" GroupRef="ca0e8">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel="PI3Kmediated" GraphId="a53e9">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel="Adenylyl cyclasemediated" GraphId="e3274" GroupRef="fdad2">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel="PKA dependent" GraphId="d15dc" GroupRef="d2014">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel="Adenylyl cyclasemediated" GraphId="b8e07" GroupRef="d2014">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel="Paracrine regulation of glucocorticoiudsecretagogue" GraphId="f8327" GroupRef="d2014">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="PKA dependent" GraphId="cccdd" GroupRef="f9e28">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel="Adenylyl cyclasemediated" GraphId="f4a91" GroupRef="f9e28">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel="Paracrine regulation of glucocorticoiudsecretagogue" GraphId="c3ac2" GroupRef="f9e28">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape GraphId="d4635" GroupRef="b40a1">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="GALR2" GraphId="a088b" GroupRef="b40a1">
    <Comment>[Pubmed: 24168112] have shown that GAL stimulates GALR2 receptor and induces dephosphorylation of MAPK1 in HEp-2 and KB cell lines.</Comment>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="GALR1" GraphId="fe1d1" GroupRef="b40a1">
    <Comment>[Pubmed: 24168112] have shown that GAL stimulates GALR2 receptor and induces dephosphorylation of MAPK1 in HEp-2 and KB cell lines.</Comment>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="DNA" GraphId="f35e4" GroupRef="f2837">
    <Graphics ShapeType="RoundedRectangle" LineStyle="Broken" Color="ff6600"/>
  </Shape>
  <Shape TextLabel="&#10;    Nucleus " GraphId="cc050" GroupRef="f2837">
    <Graphics Align="Left" ShapeType="Oval" Color="666666"/>
  </Shape>
  <Shape TextLabel="CREB1" GraphId="a21fa" GroupRef="f2837">
    <Comment>[Pubmed:28196718] have shown that GAL or M617 stimulates GALR1 and induces increased CREB DNA binding to the YAP1 promoter in mouse cholangiocytes cell line </Comment>
    <BiopaxRef>a25</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="Anti-depressive activity" GraphId="f29b3" GroupRef="b40a1">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel="Y204" GraphId="c516e">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="Y187" GraphId="fdb92">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T202" GraphId="f2125">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T185" GraphId="d35b7">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="AKT1" GraphId="a09a8" GroupRef="a69e3">
    <Comment>[Pubmed:17076662] have shown that GAL stimulates GALR2 and induces phosphorylation of AKT1 at Ser473 in mice DRG neurons.</Comment>
    <BiopaxRef>a14</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="S473&#10;" GraphId="d3cf3" GroupRef="a69e3">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="MAPK3" GraphId="b8ed3" GroupRef="a69e3">
    <Comment>[Pubmed: 21345369] have shown that GAL stimulates GALR1 and induces phosphorylation of MAPK3 mediated by Rap1 in UM-SCC-1 cell line</Comment>
    <BiopaxRef>f41</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="Role in nociceptionand neurondevelopment" GraphId="f6308" GroupRef="a69e3">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape TextLabel=" Induces adipogenesis&#10;" GraphId="ccc5e">
    <Graphics ShapeType="None" Color="cc0000"/>
  </Shape>
  <Shape GraphId="c05e3">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="P" GraphId="ac7a6">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape GraphId="a1ae9">
    <Graphics ShapeType="Oval" Color="ff3366"/>
  </Shape>
  <Shape TextLabel="DNA" GraphId="de94c">
    <Graphics ShapeType="RoundedRectangle" LineStyle="Broken" Color="ff6600"/>
  </Shape>
  <Shape GraphId="b7181">
    <Graphics ShapeType="Arc"/>
  </Shape>
  <Shape TextLabel="PKCdependent" GraphId="e620d" GroupRef="b4aea">
    <Graphics FillColor="ffffff" ShapeType="None"/>
  </Shape>
  <Shape TextLabel="TBC1D4" GraphId="bb8e1">
    <Comment> [Pubmed:29183756] have shown that M1145 stimulates GALR2 and induces phosphorylation of TBC1D4 at Thr 642 in skeletal muscles of high fat diest fed obese mice. </Comment>
    <BiopaxRef>ccf</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="S473&#10;" GraphId="b9fd4">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="TBC1D4" GraphId="d58ae" GroupRef="ec43a">
    <BiopaxRef>df7</BiopaxRef>
    <BiopaxRef>cb4</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="T642" GraphId="d2ad7" GroupRef="ec43a">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="AKT1" GraphId="de9c4" GroupRef="ec43a">
    <BiopaxRef>edd</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="S473&#10;" GraphId="d50c3" GroupRef="ec43a">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="MAPK14" GraphId="b5a3b">
    <Comment>[Pubmed:24568968]have shown that GAL stimulates GALR2 and induces phosphorylation of MAPK14 at Thr 180 and Tyr 182 in UM-SCC-1 and UM-SCC-81B SSCHN cell lines and pcDNA control cells.</Comment>
    <BiopaxRef>af8</BiopaxRef>
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="Y182" GraphId="d199a">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="T180" GraphId="d9805">
    <Graphics ShapeType="RoundedRectangle"/>
  </Shape>
  <Shape TextLabel="GALR3" GraphId="bcac4">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="GALR1" GraphId="ed53b" GroupRef="b33e7">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="GALR1" GraphId="fda54" GroupRef="e196b">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="f8210" GroupRef="e196b">
    <Graphics ShapeType="Oval" LineStyle="Broken" Color="ff00ff"/>
  </Shape>
  <Shape GraphId="f2246" GroupRef="d2f5a">
    <Graphics FillColor="00cc00" ShapeType="Triangle" Color="00cc00"/>
  </Shape>
  <Shape GraphId="bb92a" GroupRef="d7a58">
    <Graphics FillColor="ffffff" ShapeType="Triangle"/>
  </Shape>
  <Shape GraphId="f451f" GroupRef="f0ba0">
    <Graphics FillColor="ffffff" ShapeType="Triangle"/>
  </Shape>
  <Shape GraphId="daf83" GroupRef="afdbd">
    <Graphics FillColor="00cccc" ShapeType="Triangle" Color="00cccc"/>
  </Shape>
  <Shape GraphId="b58fa" GroupRef="c4263">
    <Graphics FillColor="0033cc" ShapeType="Triangle" Color="0033cc"/>
  </Shape>
  <Shape GraphId="e234d" GroupRef="b84a9">
    <Graphics FillColor="ff00ff" ShapeType="Triangle" Color="ff00ff"/>
  </Shape>
  <Shape GraphId="e7e0b" GroupRef="a379f">
    <Graphics FillColor="00cccc" ShapeType="Triangle" Color="00cccc"/>
  </Shape>
  <Shape GraphId="e726f" GroupRef="e193c">
    <Graphics FillColor="ff00ff" ShapeType="Triangle" Color="ff00ff"/>
  </Shape>
  <Shape GraphId="e1063" GroupRef="e193c">
    <Graphics FillColor="ff00ff" ShapeType="Triangle" Color="ff00ff"/>
  </Shape>
  <Group GroupId="a8b96" Style="Group"/>
  <Group GroupId="d2f5a" Style="Group"/>
  <Group GroupId="d7a58" Style="Group"/>
  <Group GroupId="f0ba0" Style="Group"/>
  <Group GroupId="d082d" Style="Group"/>
  <Group GroupId="afdbd" Style="Group"/>
  <Group GroupId="c4263" Style="Group"/>
  <Group GroupId="a379f" Style="Group"/>
  <Group GroupId="b84a9" Style="Group"/>
  <Group GroupId="e193c" Style="Group"/>
  <Group GroupId="a04b5" Style="Group"/>
  <Group GroupId="e5dde" Style="Group"/>
  <Group GroupId="e6f3b" Style="Group"/>
  <Group GroupId="ef24f" Style="Group"/>
  <Group GroupId="c1b2e" Style="Group"/>
  <Group GroupId="fdad2" Style="Group"/>
  <Group GroupId="d2379" Style="Group"/>
  <Group GroupId="e7542" Style="Group"/>
  <Group GroupId="b4aea" Style="Group"/>
  <Group GroupId="b24d0" Style="Group"/>
  <Group GroupId="b08a2" Style="Group"/>
  <Group GroupId="d00eb" Style="Group"/>
  <Group GroupId="f4b33" Style="Group"/>
  <Group GroupId="b40a1" Style="Group"/>
  <Group GroupId="b1f55" Style="Group"/>
  <Group GroupId="a69e3" Style="Group"/>
  <Group GroupId="eb7b5" Style="Group"/>
  <Group GroupId="ebaaa" Style="Group"/>
  <Group GroupId="af65e" Style="Group"/>
  <Group GroupId="a85fd" Style="Group"/>
  <Group GroupId="ce62c" Style="Group"/>
  <Group GroupId="a4d23" Style="Group"/>
  <Group GroupId="f1a15" Style="Group"/>
  <Group GroupId="e1fcf" GraphId="a02f4" Style="Group"/>
  <Group GroupId="ea2e5" GraphId="a4bb7" Style="Group"/>
  <Group GroupId="ca2d4" GraphId="a725f" Style="Group"/>
  <Group GroupId="c7409" GraphId="a9380" Style="Group"/>
  <Group GroupId="dca84" GraphId="ac09f" Style="Group"/>
  <Group GroupId="d885b" GraphId="b0c85" Style="Group"/>
  <Group GroupId="cdf7b" GraphId="b4642" Style="Group"/>
  <Group GroupId="e196b" GraphId="b4709" Style="Group"/>
  <Group GroupId="f9e28" GraphId="b5d5b" Style="Group"/>
  <Group GroupId="bd62c" GraphId="b83f2" Style="Group"/>
  <Group GroupId="df2a5" GraphId="b976e" Style="Group"/>
  <Group GroupId="f2837" GraphId="b978d" Style="Group"/>
  <Group GroupId="b4a4f" GraphId="bd719" Style="Group"/>
  <Group GroupId="ed3c2" GraphId="c30ad" Style="Group"/>
  <Group GroupId="de7ad" GraphId="ce510" Style="Group"/>
  <Group GroupId="a2009" GraphId="d763b" Style="Group"/>
  <Group GroupId="ec43a" GraphId="d82f4" Style="Group"/>
  <Group GroupId="d2014" GraphId="db84c" Style="Group"/>
  <Group GroupId="f6238" GraphId="dfc19" Style="Group"/>
  <Group GroupId="ca0e8" GraphId="e0130" Style="Group"/>
  <Group GroupId="ab62a" GraphId="e09e0" Style="Group"/>
  <Group GroupId="bc3d6" GraphId="e163a" Style="Group"/>
  <Group GroupId="e64e3" GraphId="ec377" Style="Group"/>
  <Group GroupId="a3e42" GraphId="f678d" Style="Group"/>
  <Group GroupId="a60a3" GraphId="f85b1" Style="Group"/>
  <Group GroupId="b33e7" GraphId="fb597" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bd1">
      <bp:ID >24168112</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.</bp:TITLE>
      <bp:SOURCE >Cancer Sci</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Uehara T</bp:AUTHORS>
      <bp:AUTHORS >Kanazawa T</bp:AUTHORS>
      <bp:AUTHORS >Mizukami H</bp:AUTHORS>
      <bp:AUTHORS >Uchibori R</bp:AUTHORS>
      <bp:AUTHORS >Tsukahara T</bp:AUTHORS>
      <bp:AUTHORS >Urabe M</bp:AUTHORS>
      <bp:AUTHORS >Kume A</bp:AUTHORS>
      <bp:AUTHORS >Misawa K</bp:AUTHORS>
      <bp:AUTHORS >Carey TE</bp:AUTHORS>
      <bp:AUTHORS >Suzuki M</bp:AUTHORS>
      <bp:AUTHORS >Ichimura K</bp:AUTHORS>
      <bp:AUTHORS >Ozawa K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f61">
      <bp:ID >15471987</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Visualization of a functionally enhanced GFP-tagged galanin R2 receptor in PC12 cells: constitutive and ligand-induced internalization.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Xia S</bp:AUTHORS>
      <bp:AUTHORS >Kjaer S</bp:AUTHORS>
      <bp:AUTHORS >Zheng K</bp:AUTHORS>
      <bp:AUTHORS >Hu PS</bp:AUTHORS>
      <bp:AUTHORS >Bai L</bp:AUTHORS>
      <bp:AUTHORS >Jia JY</bp:AUTHORS>
      <bp:AUTHORS >Rigler R</bp:AUTHORS>
      <bp:AUTHORS >Pramanik A</bp:AUTHORS>
      <bp:AUTHORS >Xu T</bp:AUTHORS>
      <bp:AUTHORS >H&#246;kfelt T</bp:AUTHORS>
      <bp:AUTHORS >Xu ZQ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fa6">
      <bp:ID >17263796</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage.</bp:TITLE>
      <bp:SOURCE >J Neurochem</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Elliott-Hunt CR</bp:AUTHORS>
      <bp:AUTHORS >Pope RJ</bp:AUTHORS>
      <bp:AUTHORS >Vanderplank P</bp:AUTHORS>
      <bp:AUTHORS >Wynick D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cb4">
      <bp:ID >27041232</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Central injection of GALR1 agonist M617 attenuates diabetic rat skeletal muscle insulin resistance through the Akt/AS160/GLUT4 pathway.</bp:TITLE>
      <bp:SOURCE >Mech Ageing Dev</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Fang P</bp:AUTHORS>
      <bp:AUTHORS >Yu M</bp:AUTHORS>
      <bp:AUTHORS >He B</bp:AUTHORS>
      <bp:AUTHORS >Guo L</bp:AUTHORS>
      <bp:AUTHORS >Huang X</bp:AUTHORS>
      <bp:AUTHORS >Kong G</bp:AUTHORS>
      <bp:AUTHORS >Shi M</bp:AUTHORS>
      <bp:AUTHORS >Zhu Y</bp:AUTHORS>
      <bp:AUTHORS >Bo P</bp:AUTHORS>
      <bp:AUTHORS >Zhang Z</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a65">
      <bp:ID >25405608</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A role of supraspinal galanin in behavioural hyperalgesia in the rat.</bp:TITLE>
      <bp:SOURCE >PLoS One</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Amorim D</bp:AUTHORS>
      <bp:AUTHORS >David-Pereira A</bp:AUTHORS>
      <bp:AUTHORS >Marques P</bp:AUTHORS>
      <bp:AUTHORS >Puga S</bp:AUTHORS>
      <bp:AUTHORS >Rebelo P</bp:AUTHORS>
      <bp:AUTHORS >Costa P</bp:AUTHORS>
      <bp:AUTHORS >Pertovaara A</bp:AUTHORS>
      <bp:AUTHORS >Almeida A</bp:AUTHORS>
      <bp:AUTHORS >Pinto-Ribeiro F</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="edd">
      <bp:ID >17384686</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Kanazawa T</bp:AUTHORS>
      <bp:AUTHORS >Iwashita T</bp:AUTHORS>
      <bp:AUTHORS >Kommareddi P</bp:AUTHORS>
      <bp:AUTHORS >Nair T</bp:AUTHORS>
      <bp:AUTHORS >Misawa K</bp:AUTHORS>
      <bp:AUTHORS >Misawa Y</bp:AUTHORS>
      <bp:AUTHORS >Ueda Y</bp:AUTHORS>
      <bp:AUTHORS >Tono T</bp:AUTHORS>
      <bp:AUTHORS >Carey TE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c33">
      <bp:ID >1782695</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[San-jie cream in the treatment and prevention of muscular lumps through intramuscular injections].</bp:TITLE>
      <bp:SOURCE >Zhonghua Hu Li Za Zhi</bp:SOURCE>
      <bp:YEAR >1991</bp:YEAR>
      <bp:AUTHORS >Li L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d71">
      <bp:ID >19272414</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Bidirectional regulation of stress responses by galanin in mice: involvement of galanin receptor subtype 1.</bp:TITLE>
      <bp:SOURCE >Neuroscience</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Mitsukawa K</bp:AUTHORS>
      <bp:AUTHORS >Lu X</bp:AUTHORS>
      <bp:AUTHORS >Bartfai T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="df7">
      <bp:ID >27127795</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Central Administration of Galanin Receptor 1 Agonist Boosted Insulin Sensitivity in Adipose Cells of Diabetic Rats.</bp:TITLE>
      <bp:SOURCE >J Diabetes Res</bp:SOURCE>
      <bp:YEAR >2016</bp:YEAR>
      <bp:AUTHORS >Zhang Z</bp:AUTHORS>
      <bp:AUTHORS >Fang P</bp:AUTHORS>
      <bp:AUTHORS >He B</bp:AUTHORS>
      <bp:AUTHORS >Guo L</bp:AUTHORS>
      <bp:AUTHORS >Runesson J</bp:AUTHORS>
      <bp:AUTHORS >Langel &#220;</bp:AUTHORS>
      <bp:AUTHORS >Shi M</bp:AUTHORS>
      <bp:AUTHORS >Zhu Y</bp:AUTHORS>
      <bp:AUTHORS >Bo P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="efc">
      <bp:ID >25690510</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055.</bp:TITLE>
      <bp:SOURCE >Neuropeptides</bp:SOURCE>
      <bp:YEAR >2015</bp:YEAR>
      <bp:AUTHORS >Flynn SP</bp:AUTHORS>
      <bp:AUTHORS >White HS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fbd">
      <bp:ID >24726665</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Galanin promotes neuronal differentiation from neural progenitor cells in vitro and contributes to the generation of new olfactory neurons in the adult mouse brain.</bp:TITLE>
      <bp:SOURCE >Exp Neurol</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Cordero-Llana O</bp:AUTHORS>
      <bp:AUTHORS >Rinaldi F</bp:AUTHORS>
      <bp:AUTHORS >Brennan PA</bp:AUTHORS>
      <bp:AUTHORS >Wynick D</bp:AUTHORS>
      <bp:AUTHORS >Caldwell MA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d22">
      <bp:ID >21226711</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Functional importance of inositol-1,4,5-triphosphate-induced intracellular Ca2+ mobilization in galanin-induced microglial migration.</bp:TITLE>
      <bp:SOURCE >J Neurochem</bp:SOURCE>
      <bp:YEAR >2011</bp:YEAR>
      <bp:AUTHORS >Ifuku M</bp:AUTHORS>
      <bp:AUTHORS >Okuno Y</bp:AUTHORS>
      <bp:AUTHORS >Yamakawa Y</bp:AUTHORS>
      <bp:AUTHORS >Izumi K</bp:AUTHORS>
      <bp:AUTHORS >Seifert S</bp:AUTHORS>
      <bp:AUTHORS >Kettenmann H</bp:AUTHORS>
      <bp:AUTHORS >Noda M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f41">
      <bp:ID >21345369</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma.</bp:TITLE>
      <bp:SOURCE >Cell Signal</bp:SOURCE>
      <bp:YEAR >2011</bp:YEAR>
      <bp:AUTHORS >Banerjee R</bp:AUTHORS>
      <bp:AUTHORS >Henson BS</bp:AUTHORS>
      <bp:AUTHORS >Russo N</bp:AUTHORS>
      <bp:AUTHORS >Tsodikov A</bp:AUTHORS>
      <bp:AUTHORS >D'Silva NJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e2f">
      <bp:ID >20183829</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Diet-induced obesity regulates the galanin-mediated signaling cascade in the adipose tissue of mice.</bp:TITLE>
      <bp:SOURCE >Mol Nutr Food Res</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:AUTHORS >Kim A</bp:AUTHORS>
      <bp:AUTHORS >Park T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b9c">
      <bp:ID >23897649</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >GABAergic terminals are a source of galanin to modulate cholinergic neuron development in the neonatal forebrain.</bp:TITLE>
      <bp:SOURCE >Cereb Cortex</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Keimpema E</bp:AUTHORS>
      <bp:AUTHORS >Zheng K</bp:AUTHORS>
      <bp:AUTHORS >Barde SS</bp:AUTHORS>
      <bp:AUTHORS >Berghuis P</bp:AUTHORS>
      <bp:AUTHORS >Dobszay MB</bp:AUTHORS>
      <bp:AUTHORS >Schnell R</bp:AUTHORS>
      <bp:AUTHORS >Mulder J</bp:AUTHORS>
      <bp:AUTHORS >Luiten PG</bp:AUTHORS>
      <bp:AUTHORS >Xu ZD</bp:AUTHORS>
      <bp:AUTHORS >Runesson J</bp:AUTHORS>
      <bp:AUTHORS >Langel &#220;</bp:AUTHORS>
      <bp:AUTHORS >Lu B</bp:AUTHORS>
      <bp:AUTHORS >H&#246;kfelt T</bp:AUTHORS>
      <bp:AUTHORS >Harkany T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cdf">
      <bp:ID >28203483</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Galanin Protects from Caspase-8/12-initiated Neuronal Apoptosis in the Ischemic Mouse Brain via GalR1.</bp:TITLE>
      <bp:SOURCE >Aging Dis</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Li Y</bp:AUTHORS>
      <bp:AUTHORS >Mei Z</bp:AUTHORS>
      <bp:AUTHORS >Liu S</bp:AUTHORS>
      <bp:AUTHORS >Wang T</bp:AUTHORS>
      <bp:AUTHORS >Li H</bp:AUTHORS>
      <bp:AUTHORS >Li XX</bp:AUTHORS>
      <bp:AUTHORS >Han S</bp:AUTHORS>
      <bp:AUTHORS >Yang Y</bp:AUTHORS>
      <bp:AUTHORS >Li J</bp:AUTHORS>
      <bp:AUTHORS >Xu ZD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a14">
      <bp:ID >17076662</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mice deficient for galanin receptor 2 have decreased neurite outgrowth from adult sensory neurons and impaired pain-like behaviour.</bp:TITLE>
      <bp:SOURCE >J Neurochem</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Hobson SA</bp:AUTHORS>
      <bp:AUTHORS >Holmes FE</bp:AUTHORS>
      <bp:AUTHORS >Kerr NC</bp:AUTHORS>
      <bp:AUTHORS >Pope RJ</bp:AUTHORS>
      <bp:AUTHORS >Wynick D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a97">
      <bp:ID >9928160</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Galanin causes Cl- secretion in the human colon. Potential significance of inflammation-associated NF-kappa B activation on galanin-1 receptor expression and function.</bp:TITLE>
      <bp:SOURCE >Ann N Y Acad Sci</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Benya RV</bp:AUTHORS>
      <bp:AUTHORS >Matkowskyj KA</bp:AUTHORS>
      <bp:AUTHORS >Danilkovich A</bp:AUTHORS>
      <bp:AUTHORS >Hecht G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c89">
      <bp:ID >17637475</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.</bp:TITLE>
      <bp:SOURCE >Neuropeptides</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Rajarao SJ</bp:AUTHORS>
      <bp:AUTHORS >Platt B</bp:AUTHORS>
      <bp:AUTHORS >Sukoff SJ</bp:AUTHORS>
      <bp:AUTHORS >Lin Q</bp:AUTHORS>
      <bp:AUTHORS >Bender CN</bp:AUTHORS>
      <bp:AUTHORS >Nieuwenhuijsen BW</bp:AUTHORS>
      <bp:AUTHORS >Ring RH</bp:AUTHORS>
      <bp:AUTHORS >Schechter LE</bp:AUTHORS>
      <bp:AUTHORS >Rosenzweig-Lipson S</bp:AUTHORS>
      <bp:AUTHORS >Beyer CE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d11">
      <bp:ID >15885916</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice.</bp:TITLE>
      <bp:SOURCE >Neuroscience</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Badie-Mahdavi H</bp:AUTHORS>
      <bp:AUTHORS >Lu X</bp:AUTHORS>
      <bp:AUTHORS >Behrens MM</bp:AUTHORS>
      <bp:AUTHORS >Bartfai T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c5c">
      <bp:ID >10980593</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Wittau N</bp:AUTHORS>
      <bp:AUTHORS >Grosse R</bp:AUTHORS>
      <bp:AUTHORS >Kalkbrenner F</bp:AUTHORS>
      <bp:AUTHORS >Gohla A</bp:AUTHORS>
      <bp:AUTHORS >Schultz G</bp:AUTHORS>
      <bp:AUTHORS >Gudermann T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af8">
      <bp:ID >24568968</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.</bp:TITLE>
      <bp:SOURCE >Mol Cancer Ther</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Banerjee R</bp:AUTHORS>
      <bp:AUTHORS >Van Tubergen EA</bp:AUTHORS>
      <bp:AUTHORS >Scanlon CS</bp:AUTHORS>
      <bp:AUTHORS >Vander Broek R</bp:AUTHORS>
      <bp:AUTHORS >Lints JP</bp:AUTHORS>
      <bp:AUTHORS >Liu M</bp:AUTHORS>
      <bp:AUTHORS >Russo N</bp:AUTHORS>
      <bp:AUTHORS >Inglehart RC</bp:AUTHORS>
      <bp:AUTHORS >Wang Y</bp:AUTHORS>
      <bp:AUTHORS >Polverini PJ</bp:AUTHORS>
      <bp:AUTHORS >Kirkwood KL</bp:AUTHORS>
      <bp:AUTHORS >D'Silva NJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e84">
      <bp:ID >27410235</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activated central galanin type 1 receptor alleviated insulin resistance in diabetic rat muscle.</bp:TITLE>
      <bp:SOURCE >J Neurosci Res</bp:SOURCE>
      <bp:YEAR >2016</bp:YEAR>
      <bp:AUTHORS >Bu L</bp:AUTHORS>
      <bp:AUTHORS >Chang X</bp:AUTHORS>
      <bp:AUTHORS >Cheng X</bp:AUTHORS>
      <bp:AUTHORS >Yao Q</bp:AUTHORS>
      <bp:AUTHORS >Su B</bp:AUTHORS>
      <bp:AUTHORS >Sheng C</bp:AUTHORS>
      <bp:AUTHORS >Qu S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c8b">
      <bp:ID >27592409</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ala&lt;sup&gt;5&lt;/sup&gt;-galanin (2-11) is a GAL&lt;sub&gt;2&lt;/sub&gt;R specific galanin analogue.</bp:TITLE>
      <bp:SOURCE >Neuropeptides</bp:SOURCE>
      <bp:YEAR >2016</bp:YEAR>
      <bp:AUTHORS >Webling K</bp:AUTHORS>
      <bp:AUTHORS >Runesson J</bp:AUTHORS>
      <bp:AUTHORS >Lang A</bp:AUTHORS>
      <bp:AUTHORS >Saar I</bp:AUTHORS>
      <bp:AUTHORS >Kofler B</bp:AUTHORS>
      <bp:AUTHORS >Langel &#220;</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f53">
      <bp:ID >22076657</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >G-protein-coupled receptor-mediated MAPK and PI3-kinase signaling is maintained in Chinese hamster ovary cells after &#947;-irradiation.</bp:TITLE>
      <bp:SOURCE >J Biomol Screen</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >Osmond RI</bp:AUTHORS>
      <bp:AUTHORS >Martin-Harris MH</bp:AUTHORS>
      <bp:AUTHORS >Crouch MF</bp:AUTHORS>
      <bp:AUTHORS >Park J</bp:AUTHORS>
      <bp:AUTHORS >Morreale E</bp:AUTHORS>
      <bp:AUTHORS >Dupriez VJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b75">
      <bp:ID >27359210</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Galanin Activates G Protein Gated Inwardly Rectifying Potassium Channels and Suppresses Kisspeptin-10 Activation of GnRH Neurons.</bp:TITLE>
      <bp:SOURCE >Endocrinology</bp:SOURCE>
      <bp:YEAR >2016</bp:YEAR>
      <bp:AUTHORS >Constantin S</bp:AUTHORS>
      <bp:AUTHORS >Wray S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cea">
      <bp:ID >17143559</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Galanin enhances corticosterone secretion from dispersed rat adrenocortical cells through the activation of GAL-R1 and GAL-R2 receptors coupled to the adenylate cyclase-dependent signaling cascade.</bp:TITLE>
      <bp:SOURCE >Int J Mol Med</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Andreis PG</bp:AUTHORS>
      <bp:AUTHORS >Malendowicz LK</bp:AUTHORS>
      <bp:AUTHORS >Rebuffat P</bp:AUTHORS>
      <bp:AUTHORS >Spinazzi R</bp:AUTHORS>
      <bp:AUTHORS >Ziolkowska A</bp:AUTHORS>
      <bp:AUTHORS >Nussdorfer GG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a94">
      <bp:ID >22308501</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Go2 G protein mediates galanin inhibitory effects on insulin release from pancreatic &#946; cells.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >Tang G</bp:AUTHORS>
      <bp:AUTHORS >Wang Y</bp:AUTHORS>
      <bp:AUTHORS >Park S</bp:AUTHORS>
      <bp:AUTHORS >Bajpayee NS</bp:AUTHORS>
      <bp:AUTHORS >Vi D</bp:AUTHORS>
      <bp:AUTHORS >Nagaoka Y</bp:AUTHORS>
      <bp:AUTHORS >Birnbaumer L</bp:AUTHORS>
      <bp:AUTHORS >Jiang M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ccf">
      <bp:ID >29183756</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activiated galanin receptor 2 attenuates insulin resistance in skeletal muscle of obese mice.</bp:TITLE>
      <bp:SOURCE >Peptides</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Fang P</bp:AUTHORS>
      <bp:AUTHORS >Zhang L</bp:AUTHORS>
      <bp:AUTHORS >Yu M</bp:AUTHORS>
      <bp:AUTHORS >Sheng Z</bp:AUTHORS>
      <bp:AUTHORS >Shi M</bp:AUTHORS>
      <bp:AUTHORS >Zhu Y</bp:AUTHORS>
      <bp:AUTHORS >Zhang Z</bp:AUTHORS>
      <bp:AUTHORS >Bo P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b77">
      <bp:ID >25152404</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Borroto-Escuela DO</bp:AUTHORS>
      <bp:AUTHORS >Narvaez M</bp:AUTHORS>
      <bp:AUTHORS >Di Palma M</bp:AUTHORS>
      <bp:AUTHORS >Calvo F</bp:AUTHORS>
      <bp:AUTHORS >Rodriguez D</bp:AUTHORS>
      <bp:AUTHORS >Millon C</bp:AUTHORS>
      <bp:AUTHORS >Carlsson J</bp:AUTHORS>
      <bp:AUTHORS >Agnati LF</bp:AUTHORS>
      <bp:AUTHORS >Garriga P</bp:AUTHORS>
      <bp:AUTHORS >D&#237;az-Cabiale Z</bp:AUTHORS>
      <bp:AUTHORS >Fuxe K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ca0">
      <bp:ID >15934937</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP-dependent mechanism.</bp:TITLE>
      <bp:SOURCE >J Neurochem</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Hawes JJ</bp:AUTHORS>
      <bp:AUTHORS >Brunzell DH</bp:AUTHORS>
      <bp:AUTHORS >Wynick D</bp:AUTHORS>
      <bp:AUTHORS >Zachariou V</bp:AUTHORS>
      <bp:AUTHORS >Picciotto MR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bfe">
      <bp:ID >25017118</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Galanin receptor 2 utilizes distinct signaling pathways to suppress cell proliferation and induce apoptosis in HNSCC.</bp:TITLE>
      <bp:SOURCE >Mol Med Rep</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Kanazawa T</bp:AUTHORS>
      <bp:AUTHORS >Misawa K</bp:AUTHORS>
      <bp:AUTHORS >Misawa Y</bp:AUTHORS>
      <bp:AUTHORS >Maruta M</bp:AUTHORS>
      <bp:AUTHORS >Uehara T</bp:AUTHORS>
      <bp:AUTHORS >Kawada K</bp:AUTHORS>
      <bp:AUTHORS >Nagatomo T</bp:AUTHORS>
      <bp:AUTHORS >Ichimura K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a96">
      <bp:ID >18272487</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2).</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Tofighi R</bp:AUTHORS>
      <bp:AUTHORS >Joseph B</bp:AUTHORS>
      <bp:AUTHORS >Xia S</bp:AUTHORS>
      <bp:AUTHORS >Xu ZQ</bp:AUTHORS>
      <bp:AUTHORS >Hamberger B</bp:AUTHORS>
      <bp:AUTHORS >H&#246;kfelt T</bp:AUTHORS>
      <bp:AUTHORS >Ceccatelli S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c91">
      <bp:ID >16819983</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Galanin and galanin-like peptide modulate neurite outgrowth via protein kinase C-mediated activation of extracellular signal-related kinase.</bp:TITLE>
      <bp:SOURCE >Eur J Neurosci</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Hawes JJ</bp:AUTHORS>
      <bp:AUTHORS >Narasimhaiah R</bp:AUTHORS>
      <bp:AUTHORS >Picciotto MR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a25">
      <bp:ID >28196718</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The Neuropeptide Galanin Is Up-Regulated during Cholestasis and Contributes to Cholangiocyte Proliferation.</bp:TITLE>
      <bp:SOURCE >Am J Pathol</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >McMillin M</bp:AUTHORS>
      <bp:AUTHORS >Frampton G</bp:AUTHORS>
      <bp:AUTHORS >Grant S</bp:AUTHORS>
      <bp:AUTHORS >DeMorrow S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b06">
      <bp:ID >24602615</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of galanin receptor 2 stimulates large conductance Ca(2+)-dependent K(+) (BK) channels through the IP3 pathway in human embryonic kidney (HEK293) cells.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Pan NC</bp:AUTHORS>
      <bp:AUTHORS >Bai YF</bp:AUTHORS>
      <bp:AUTHORS >Yang Y</bp:AUTHORS>
      <bp:AUTHORS >H&#246;kfelt T</bp:AUTHORS>
      <bp:AUTHORS >Xu ZQ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d0c">
      <bp:ID >15885774</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Constitutive and ligand-induced internalization of EGFP-tagged galanin R2 and Rl receptors in PC12 cells.</bp:TITLE>
      <bp:SOURCE >Neuropeptides</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Xia S</bp:AUTHORS>
      <bp:AUTHORS >Kjaer S</bp:AUTHORS>
      <bp:AUTHORS >Zheng K</bp:AUTHORS>
      <bp:AUTHORS >Hu PS</bp:AUTHORS>
      <bp:AUTHORS >Xu T</bp:AUTHORS>
      <bp:AUTHORS >H&#246;kfelt T</bp:AUTHORS>
      <bp:AUTHORS >Xu ZQ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d9a">
      <bp:ID >19276245</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.</bp:TITLE>
      <bp:SOURCE >Clin Cancer Res</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Kanazawa T</bp:AUTHORS>
      <bp:AUTHORS >Kommareddi PK</bp:AUTHORS>
      <bp:AUTHORS >Iwashita T</bp:AUTHORS>
      <bp:AUTHORS >Kumar B</bp:AUTHORS>
      <bp:AUTHORS >Misawa K</bp:AUTHORS>
      <bp:AUTHORS >Misawa Y</bp:AUTHORS>
      <bp:AUTHORS >Jang I</bp:AUTHORS>
      <bp:AUTHORS >Nair TS</bp:AUTHORS>
      <bp:AUTHORS >Iino Y</bp:AUTHORS>
      <bp:AUTHORS >Carey TE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e04">
      <bp:ID >25449850</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Central injection of GalR1 agonist M617 facilitates GLUT4 expression in cardiac muscle of type 2 diabetic rats.</bp:TITLE>
      <bp:SOURCE >Exp Gerontol</bp:SOURCE>
      <bp:YEAR >2015</bp:YEAR>
      <bp:AUTHORS >Fang P</bp:AUTHORS>
      <bp:AUTHORS >Shi M</bp:AUTHORS>
      <bp:AUTHORS >Zhu Y</bp:AUTHORS>
      <bp:AUTHORS >Zhang Z</bp:AUTHORS>
      <bp:AUTHORS >Bo P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e66">
      <bp:ID >33136286</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >An assembly of galanin-galanin receptor signaling network.</bp:TITLE>
      <bp:SOURCE >J Cell Commun Signal</bp:SOURCE>
      <bp:YEAR >2020</bp:YEAR>
      <bp:AUTHORS >Gopalakrishnan L</bp:AUTHORS>
      <bp:AUTHORS >Chatterjee O</bp:AUTHORS>
      <bp:AUTHORS >Raj C</bp:AUTHORS>
      <bp:AUTHORS >Pullimamidi D</bp:AUTHORS>
      <bp:AUTHORS >Advani J</bp:AUTHORS>
      <bp:AUTHORS >Mahadevan A</bp:AUTHORS>
      <bp:AUTHORS >Keshava Prasad TS</bp:AUTHORS>
    </bp:PublicationXref>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>nervous system disease</bp:TERM><bp:ID>DOID:863</bp:ID><bp:Ontology>Disease</bp:Ontology></bp:openControlledVocabulary><bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>signaling pathway</bp:TERM><bp:ID>PW:0000003</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>